Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ≥50% (vol 14, pg 1, 2022)

被引:0
|
作者
Freemantle, N.
Xu, Y.
Wilson, F. R.
机构
关键词
D O I
10.1177/17588359221127078
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression >50%
    Freemantle, Nick
    Xu, Yingxin
    Wilson, Florence R.
    Guyot, Patricia
    Chen, Chieh-, I
    Keeping, Sam
    Konidaris, Gerasimos
    Chan, Keith
    Kuznik, Andreas
    Atsou, Kokuvi
    Glowienka, Emily
    Pouliot, Jean-Francois
    Gullo, Giuseppe
    Rietschel, Petra
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [2] PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-Analysis
    Majem, Margarita
    Cobo, Manuel
    Isla, Dolores
    Marquez-Medina, Diego
    Rodriguez-Abreu, Delvys
    Casal-Rubio, Joaquin
    Moran-Bueno, Teresa
    Bernabe-Caro, Reyes
    Perez-Parente, Diego
    Ruiz-Gracia, Pedro
    Arroyo, Marta Marina
    Paz-Ares, Luis
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (07)
  • [3] PD-L1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer in PD-L1 Positive Patients: A Safety Data Network Meta-Analysis
    Garcia Campelo, Maria Rosario
    Arriola, Edurne
    Campos Balea, Begona
    Lopez-Brea, Marta
    Fuentes-Pradera, Jose
    de Castro Carpeno, Javier
    Aguado, Carlos
    Perez Parente, Diego
    de Oro Pulido, Fidel
    Ruiz-Gracia, Pedro
    Rodriguez-Abreu, Delvys
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
  • [4] First-Line Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer (NSCLC) - A Network Meta-Analysis by PD-L1
    San Tan, P.
    Nazareth Aguiar Junior, P.
    Husnain, M.
    Haaland, B.
    Lopes, G.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S467 - S467
  • [5] PD-L1 inhibitors as monotherapy for the first-line treatment of non-small cell lung cancer in PD-L1 positive patients: A safety data network meta-analysis
    Garcia Campelo, M. R.
    Arriola Aperribay, E.
    Campos Balea, B.
    Lopez-Brea, M.
    Fuentes Pradera, J.
    de Castro Carpeno, J.
    Aguado, C.
    Perez Parente, D.
    de Oro-Pulido, F.
    Rodriguez Abreu, D.
    ANNALS OF ONCOLOGY, 2021, 32 : S1413 - S1414
  • [6] First-line treatment options for advanced non-small cell lung cancer patients with PD-L1 ≥ 50%: a systematic review and network meta-analysis
    He, Mingfeng
    Zheng, Taihao
    Zhang, Xiaoyue
    Peng, Yuan
    Jiang, Xuan
    Huang, Yusheng
    Tan, Benxu
    Yang, Zhenzhou
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (06) : 1345 - 1355
  • [7] First-line treatment options for advanced non-small cell lung cancer patients with PD-L1 ≥ 50%: a systematic review and network meta-analysis
    Mingfeng He
    Taihao Zheng
    Xiaoyue Zhang
    Yuan Peng
    Xuan Jiang
    Yusheng Huang
    Benxu Tan
    Zhenzhou Yang
    Cancer Immunology, Immunotherapy, 2022, 71 : 1345 - 1355
  • [8] Network meta-analysis of first-line immune checkpoint inhibitor therapy in advanced non-squamous non-small cell lung cancer patients with PD-L1 expression ≥ 50%
    Chen, Wei
    Chen, Jiayi
    Zhang, Lin
    Cheng, Sheng
    Yu, Junxian
    BMC CANCER, 2023, 23 (01)
  • [9] Network meta-analysis of first-line immune checkpoint inhibitor therapy in advanced non-squamous non-small cell lung cancer patients with PD-L1 expression ≥ 50%
    Wei Chen
    Jiayi Chen
    Lin Zhang
    Sheng Cheng
    Junxian Yu
    BMC Cancer, 23
  • [10] Network meta-analysis (NMA) of immuno-oncology (IO) monotherapy as first-line (1L) treatments (txs) for advanced non-small cell lung cancer (NSCLC) with PD-L1 expression ≥50%.
    Freemantle, Nicholas
    Xu, Yingxin
    Wilson, Florence
    Guyot, Patricia
    Chen, Chieh-I
    Keeping, Sam
    Konidaris, Gerasimos
    Chan, Keith
    Kuznik, Andreas
    Atsou, Kokuvi
    Glowienka, Emily
    Stow, Lisa
    Pouliot, Jean-Francois
    Gullo, Giuseppe
    Rietschel, Petra
    Rizvi, Naiyer A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)